Get the Stockscreener App
1.83
1.61%
-0.03
Mdxhealth Sa stock is traded at $1.83, with a volume of 8,784.
It is down -1.61% in the last 24 hours and down -8.04% over the past month.
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.
See More
Previous Close:
$1.86
Open:
$1.86
24h Volume:
8,784
Relative Volume:
0.07
Market Cap:
$92.07M
Revenue:
$63.69M
Net Income/Loss:
$-44.82M
P/E Ratio:
-0.915
EPS:
-2
Net Cash Flow:
$-30.56M
1W Performance:
-2.14%
1M Performance:
-8.04%
6M Performance:
-44.04%
1Y Performance:
-47.86%
1-Day Range:
$1.82
$1.86
1-Week Range:
$1.82
$2.01
52-Week Range:
$1.55
$3.85
Mdxhealth Sa Stock (MDXH) Company Profile
Compare MDXH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
1.83 | 92.07M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
537.19 | 205.72B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
212.11 | 149.54B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
136.30 | 39.02B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
458.91 | 37.08B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
194.77 | 34.17B | 15.41B | 1.37B | 2.11B | 7.50 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-24 | Initiated | Lake Street | Buy |
| May-31-23 | Initiated | TD Cowen | Outperform |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
Mdxhealth Sa Stock (MDXH) Latest News
MDxHealth (MDXH) Projected to Post Earnings on Wednesday - Defense World
Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26 - The Manila Times
MDxHealth Earnings Alert: Key Financial Results & Strategic Updates Unveiled Next Week - StockTitan
MDxHealth SA Provides Revenue Guidance for the Fourth Quarter of 2024, Full Year of 2024 and Year 2025 - Marketscreener.com
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance - The Manila Times
MDxHealth Reports Strong 28% Revenue Growth, Projects EBITDA Profitability in 2025 - StockTitan
Contrasting Biodesix (NASDAQ:BDSX) & MDxHealth (NASDAQ:MDXH) - Defense World
Critical Survey: BioNexus Gene Lab (NASDAQ:BGLC) versus MDxHealth (NASDAQ:MDXH) - Defense World
MDxHealth: Strong Buy On Its Cutting-Edge Urology Diagnostics (NASDAQ:MDXH) - Seeking Alpha
MDxHealth (STU:O6C1) Enterprise Value : €88.51 Mil (As of Dec. 08, 2024) - GuruFocus.com
MDxHealth SA (NASDAQ:MDXH) Q3 2024 Earnings Call Transcript - MSN
MDxHealth (CHIX:MDXHB) Enterprise Value : €102.00 Mil (As of Dec. 01, 2024) - GuruFocus.com
MDxHealth to Participate in Piper Sandler Healthcare Conference - The Manila Times
MDxHealth CEO to Present at Piper Sandler Healthcare Conference in NYC | MDXH Stock News - StockTitan
OneDigital Investment Advisors LLC Increases Stock Position in MDxHealth SA (NASDAQ:MDXH) - Defense World
MVM Partners, LLC Reduces Stake in Paragon 28 Inc - GuruFocus.com
MDxHealth SA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
MDxHealth stock hits 52-week low at $1.57 amid market challenges By Investing.com - Investing.com South Africa
MDxHealth stock hits 52-week low at $1.57 amid market challenges - Investing.com
OC500 2024: Michael McGarrity - Orange County Business Journal
AWM Investment Company's Strategic Acquisition of MDxHealth SA S - GuruFocus.com
MDxHealth stock hits 52-week low at $1.93 amid market challenges - Investing.com
MDxHealth SA (MDXH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... - Yahoo Finance
MDxHealth SA (MDXH) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
MDxHealth ADR earnings missed by $0.13, revenue topped estimates - Investing.com
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024 - The Manila Times
What To Expect From MDxHealth SA (MDXH) Q3 2024 Earnings - GuruFocus.com
MDxHealth (OTCMKTS:MXDHF) Trading Down 9.1% – Here’s Why - Defense World
Lake Street Initiates Coverage of MDxHealth (MDXH) with Buy Recommendation - MSN
MVM Partners, LLC Increases Stake in MDxHealth SA - GuruFocus.com
Liquid Biopsy Market Set for Explosive Growth by 2024-2031: Key Trends and Drivers | MDxHealth SA, Natera, Inc - EIN News
MdxHealth’s US$40 Million Ordinary Shares Offering - Global Legal Chronicle
MDxHealth stock hits 52-week low at $1.95 amid market challenges - Investing.com
Critical Analysis: MDxHealth (NASDAQ:MDXH) & Aclarion (NASDAQ:ACON) - Defense World
MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6 - The Manila Times
DLA Piper advises TD Cowen as underwriter in MdxHealth’s US$40 million public offering of ordinary shares - Legal Desire News Network
Midday Stock Roundup: STAAR Surgical CO. Shares Surge 22% - Orange County Business Journal
MDxHealth announces pricing of registered public offering - Medical Buyer
mdxHealth stock touches 52-week low at $2.0 amid market challenges - Investing.com Australia
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.62% - MSN
MDXH’s Market Whiplash: -48.98% YTD Decline, -31.40% Plunge in 30 Days - The InvestChronicle
Dow Surges Over 250 Points; Accenture Earnings Top Views - Benzinga
MDXH’s price-to-book ratio: An indicator of the company’s performance - US Post News
Crude Oil Down Over 2%; US Initial Jobless Claims Fall - Benzinga
Mdxhealth Sa Stock (MDXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.17%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):